1,865 results on '"Ueda Ryuzo"'
Search Results
2. Clinical landscape of TP73 structural variants in ATL patients
3. Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
4. Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia
5. TGFB1 mRNA expression is associated with poor prognosis and specific features of inflammation in ccRCC
6. Trametinib improves Treg selectivity of anti-CCR4 antibody by regulating CCR4 expression in CTLs in oral squamous cell carcinoma
7. Regulatory T‐cells activated in metastatic draining lymph nodes possibly suppress cancer immunity in cancer tissues of head and neck squamous cell cancer
8. Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study
9. Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab
10. CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia
11. Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors
12. CCR4 is rarely expressed in CCR4-mutated T/NK-cell lymphomas other than adult T-cell leukemia/lymphoma
13. Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma
14. T1653 Mutation in the Box α Increases the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Genotype C Infection
15. Two Subtypes of Genotype B (Ba and Bj) of Hepatitis B Virus in Japan
16. Predicting Relapse after Cessation of Lamivudine Monotherapy for Chronic Hepatitis B Virus Infection
17. Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels
18. Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia
19. Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma
20. Molecular Evolutionary Analysis of the Complete Nucleotide Sequence of Hepatitis B Virus (HBV) in a Case of HBV Infection Acquired through a Needlestick Accident
21. Progress in Clinical Use of CC Chemokine Receptor 4 Antibody for Regulatory T Cell Suppression
22. Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients
23. Supplementary Methods, Figures 1 - 7 from Antitumor Impact of p14ARF on Gefitinib-Resistant Non–Small Cell Lung Cancers
24. Data from Antitumor Impact of p14ARF on Gefitinib-Resistant Non–Small Cell Lung Cancers
25. Data from Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma
26. Supplementary Fig. from Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines
27. Supplementary Figure 1, Tables S1-6 from Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma
28. Supplementary Figure 3 from Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients
29. Clinical landscape of TP73structural variants in ATL patients
30. Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens
31. Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease
32. Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
33. Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumors
34. Landscape of immunoglobulin heavy chain gamma gene class switch recombination in patients with adult T-cell leukemia–lymphoma
35. Hiroshi Shiku, MD, PhD: In Memoriam (1943–2022)
36. CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment
37. Prognostic impact of microRNA-145 down-regulation in adult T-cell leukemia/lymphoma
38. Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma
39. Immune Status of Cervical Lymph Nodes in Head and Neck Cancer—A Surgical Oncology Perspective.
40. Global real-time quantitative reverse transcription-polymerase chain reaction detecting proto-oncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myeloma
41. Bath-PUVA Therapy Decreases Infiltrating CCR4-Expressing Tumor Cells and Regulatory T Cells in Patients With Mycosis Fungoides
42. Angioimmunoblastic T-cell lymphoma mice model
43. Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells
44. Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia–lymphoma patients with resolved HBV infection following systemic chemotherapy
45. Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
46. Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma
47. In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among Patients
48. Identification of cisplatin-resistant factor by integration of transcriptomic and proteomic data using head and neck carcinoma cell lines
49. Fatal reactivation of hepatitis B virus infection in a patient with adult T-cell leukemia–lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab
50. A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.